MedPath

Examination of Efficacy and safety of Bepotastine besilate (TALION Tablets) for pruritic skin diseases in scar

Not Applicable
Conditions
pruritic skin diseases in scar
Registration Number
JPRN-UMIN000005730
Lead Sponsor
Tokyo Woman's Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who are renal dysfunction 2)Patients who are pregnant or might be pregnant 3)Patients who are considered unsuitable for this study by the investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Subjective sign and objective symptom
Secondary Outcome Measures
NameTimeMethod
1)Subjective symptoms: itch, spontaneous pain, pain on pressure,sense of tumoral and evaluate the degree of the feeling in VAS(100mm) 2)Objective symptom : Skin symptom (color, wrinkle, luster, height, flare around the scar, expansion of the scar) last total improvement , usefulness Discontinuation rate by ineffectiveness
© Copyright 2025. All Rights Reserved by MedPath